# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001558370-16-006351
Filing Date
2016-06-10
Accepted
2016-06-10 06:10:29
Documents
5
Period of Report
2016-06-10
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | glyc-20160610x8k.htm | 8-K | 35999
2 | EX-99.1 | glyc-20160610ex9919a0459.htm | EX-99.1 | 12950
3 | EX-99.2 | glyc-20160610ex9921be6c5.htm | EX-99.2 | 16619
4 | GRAPHIC | glyc20160610ex9919a0459001.jpg | GRAPHIC | 770769
5 | GRAPHIC | glyc20160610ex9921be6c5001.jpg | GRAPHIC | 4987
| Complete submission text file | 0001558370-16-006351.txt |  | 1135360

Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36177 | Film No.: 161707295
SIC: 2834 Pharmaceutical Preparations